RESEARCH FOUNDATIONS

Our mandate is to protect communities from biological threats by building the science, the products, and the people that make Africa self-reliant in health security.

Biosecurity iconA biological symbol protected by a shield and lock.

Biosecurity

Pre-clinical infrastructure, biorisk management, and training build a skilled, biosecure workforce and the facilities to handle it responsibly.

Subunit vaccine iconA clean scientific icon showing a purified protein antigen and protective shield.

Vaccine development

Antigen discovery, adjuvant formulation and immunogenicity, toxicity and safety testing for human and animal-health candidates.

Diagnostics iconA simple scientific diagnostics icon showing a test tube, diagnostic test strip and magnifying glass.CT

Diagnostics

ELISA, RDTs and lateral-flow assays, supported by locally produced monoclonal and secondary antibodies (hybridoma and affinity-purified IgG).

Preclinical research iconA simple scientific icon showing a laboratory flask, molecular structure and research results.

Pre-clinical Research

In-vivo efficacy, toxicity and safety studies, biological-molecule production and animal-model breeding at a shared facility.

Capacity building iconPeople learning with an upward growth arrow and skill-building steps.

Capacity building

Empowering researchers and health professionals with the skills, knowledge, and tools to advance biomedical research and innovation.

Biomolecular engineering iconA clean scientific icon showing DNA, molecular components and an engineered protein.

Biomolecular Engineering

Vector and expression-system design, protein engineering and reagent optimisation the platform underneath every product.

5+

ACTIVE VENTURES

TRAINED SCIENTISTS
0 +

GLP

PRE-CLINICAL FACILITY

100yr

MAKERERE HERITAGE

Our journey

From a campus lab to a continental mission

Founding

Established at COVAB, Makerere University

CeBioTech is set up to anchor biosecurity and biomolecular research within Uganda's leading veterinary and biosciences college.

COVID-19 era

SARS-CoV-2 antigens expressed locally

Spike, nucleocapsid and RBD proteins are produced in-house, seeding the surveillance ELISA and the RePROVaD pipeline.

Scaling up

Diagnostics reach the market

An Mpox RDT and a SARS-CoV-2 test clear development as products of the Government of Uganda.

Now

Ventures, CLARF and FONSTI in motion

A cGMP facility is under construction, CLARF runs pre-clinical studies, and FONSTI links the innovation network across the continent.

Collaborating with leading institutions

GET INVOLVED

Build Africa’s Health Security

We welcome collaborators, funders, manufacturers and researchers ready to strengthen biosurveillance, biomolecular technology and biosafety across the continent.

Scroll to Top